|
|
||||||||
Meakins-Christie Laboratories, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada
To test the hypothesis that CD8+ T cells may suppress
the allergen-induced late airway response (LAR) and airway
eosinophilia, we examined the effect of administration of Ag-primed
CD8+ T cells on allergic airway responses, bronchoalveolar
lavage (BAL) leukocytes, and mRNA expression for cytokines (IL-4, IL-5,
and IFN-
) in OVA-sensitized Brown Norway rats. On day 12
postsensitization to OVA, test rats were administered 2 million
CD8+ T cells i.p. isolated from either the cervical lymph
nodes (LN group; n = 8) or the spleen (Spl group;
n = 6) of sensitized donors. On day 14, test rats
were challenged with aerosolized OVA. Control rats were administered
PBS i.p. on day 12, and challenged with OVA (n =
10) or BSA (n = 6) on day 14. The lung resistance
was measured for 8 h after challenge. BAL was performed at 8 h.
Cytospin slides of BAL were analyzed for major basic protein by
immunostaining and for cytokine mRNA by in situ hybridization. The LAR
was significantly less in the LN group (1.8 ± 0.5 U;
p < 0.01) and BSA controls (1.4 ± 0.7;
p < 0.01), but not in the Spl group (6.7 ±
2.2), compared with that in OVA controls (8.1 ± 1.8). In BAL, the
number of major basic protein-positive cells was lower in the LN and
Spl groups compared with OVA controls (p < 0.05
and p < 0.01). IL-4- and IL-5-positive cells were
decreased in the LN group compared with the OVA controls
(p < 0.01). INF-
-positive cells were increased
in the LN and Spl groups compared with the OVA controls
(p < 0.01). Serum OVA-specific IgE levels were
unaffected by CD8+ T cell transfers. These results indicate
that Ag-primed CD8+ T cells have a potent suppressive
effect on LAR.
This article has been cited by other articles:
![]() |
T. Koya, N. Miyahara, K. Takeda, S. Matsubara, H. Matsuda, C. Swasey, A. Balhorn, A. Dakhama, and E. W. Gelfand CD8+ T Cell-Mediated Airway Hyperresponsiveness and Inflammation Is Dependent on CD4+IL-4+ T Cells J. Immunol., September 1, 2007; 179(5): 2787 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Teixeira, B. P. F. Fonseca, A. Vieira-de-Abreu, B. A. Barboza, B. K. Robbs, P. T. Bozza, and J. P. B. Viola IFN-{gamma} Production by CD8+ T Cells Depends on NFAT1 Transcription Factor and Regulates Th Differentiation J. Immunol., November 1, 2005; 175(9): 5931 - 5939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukushima, T. Yamaguchi, W. Ishida, K. Fukata, R. S. Mittler, H. Yagita, and H. Ueno Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice J. Immunol., October 15, 2005; 175(8): 4897 - 4903. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyahara, K. Takeda, T. Kodama, A. Joetham, C. Taube, J.-W. Park, S. Miyahara, A. Balhorn, A. Dakhama, and E. W. Gelfand Contribution of Antigen-Primed CD8+ T Cells to the Development of Airway Hyperresponsiveness and Inflammation Is Associated with IL-13 J. Immunol., February 15, 2004; 172(4): 2549 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Krug, V. J. Erpenbeck, K. Balke, J. Petschallies, T. Tschernig, J. M. Hohlfeld, and H. Fabel Cytokine Profile of Bronchoalveolar Lavage-Derived CD4+, CD8+, and gamma delta T Cells in People with Asthma after Segmental Allergen Challenge Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |